The Pennant Group, Inc. Stock News

The Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of -22.22% and 2.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the s

The consensus price target hints at a 43.5% upside potential for The Pennant Group, Inc. (PNTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ea

The Pennant Group, Inc. (NASDAQ:PNTG ) Q2 2022 Results Conference Call August 9, 2022 12:00 PM ET Company Participants Derek Bunker - Chief Investment Officer Brent Guerisoli - Chief Executive Officer

Although 2022 hasn't gotten off to the start bullish investors were hoping for, the red ink does open the door for the best stocks under $20 to buy now. As many prominent financial advisors have menti

The Pennant Group, Inc. (PNTG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further pr

Investors need to pay close attention to The Pennant Group (PNTG) stock based on the movements in the options market lately.

By Kathryn Hardison

EAGLE, Idaho., May 16, 2022 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, annou

The Pennant Group, Inc. (NASDAQ:PNTG ) Q1 2022 Results Conference Call May 10, 2022 12:00 PM ET Company Participants Derek Bunker - Chief Investment Officer Danny Walker - Chief Executive Officer Bren

EAGLE, Idaho, March 10, 2022 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, anno

The Pennant Group, Inc. (PNTG) CEO Danny Walker on Q4 2021 Results - Earnings Call Transcript

Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ: RVMD ) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of $50.88 and a 52-week-low of $18.07. At the end of the last trading period, Revolution Medicines closed at $18.92. According to UBS, the prior rating for Amedisys Inc (NASDAQ: AMED ) was changed from Sell to Neutral. For the fourth quarter, Amedisys had an EPS of $1.18, compared to year-ago quarter EPS of $1.49. At the moment, the stock has a 52-week-high of $292.97 and a 52-week-low of $122.12. Amedisys closed at $160.24 at the end of the last trading period. For Sunstone Hotel Investors Inc (NYSE: SHO ), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. At the moment, the stock has a 52-week-high of $13.91 and a 52-week-low of $9.93. Sunstone Hotel Invts closed at $10.58 at the end of the last trading period. Wedbush upgraded the previous rating for Logitech International SA (NASDAQ: LOGI ) from Neutral to Outperform.

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ: LXRX ) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (NASDAQ: PRAX ) is likely to report earnings for its fourth quarter. • Blackstone Secured (NYSE: BXSL ) is likely to report quarterly earnings at $0.59 per share on revenue of $171.69 million. • Mersana Therapeutics (NASDAQ: MRSN ) is estimated to report earnings for its fourth quarter. • Partner Communications Co (NASDAQ: PTNR ) is expected to report earnings for its fourth quarter. • Daqo New Energy (NYSE: DQ ) is expected to report quarterly earnings at $4.58 per share on revenue of $698.65 million. • Easterly Government Props (NYSE: DEA ) is likely to report quarterly earnings at $0.10 per share on revenue of $72.20 million. • Aurinia Pharmaceuticals (NASDAQ: AUPH ) is expected to report earnings for its fourth quarter. • Kosmos Energy (NYSE: KOS ) is estimated to report quarterly earnings at $0.15 per share on revenue of $380.

EAGLE, Idaho, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, annou

EAGLE, Idaho, Dec. 23, 2021 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that Mr. Roderic W. Lewis notified the Board of Directors (the Board) that he intends to retire as a director of the company effective December 31, 2021. The Company also announced that the Board has appointed Gregory K. Morris, MD to fill the seat vacated by Mr. Lewis beginning January 1, 2022.